Growth Metrics

Eli Lilly (LLY) Total Debt (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.04%
Dec 31, 2025 -0.01%
Sep 30, 2025 6.52%
Jun 30, 2025 3.60%
Mar 31, 2025 14.48%
Dec 31, 2024 8.11%
Sep 30, 2024 7.71%
Jun 30, 2024 10.23%
Mar 31, 2024 3.91%
Dec 31, 2023 25.07%
Sep 30, 2023 7.16%
Jun 30, 2023 -0.34%
Mar 31, 2023 16.29%
Dec 31, 2022 2.20%
Sep 30, 2022 -5.50%
Jun 30, 2022 1.85%
Mar 31, 2022 -2.23%
Dec 31, 2021 -1.17%
Sep 30, 2021 3.45%
Jun 30, 2021 1.92%
Mar 31, 2021 -2.35%
Dec 31, 2020 -1.93%
Sep 30, 2020 3.64%
Jun 30, 2020 -5.24%
Mar 31, 2020 12.49%
Dec 31, 2019 0.60%
Sep 30, 2019 -3.55%
Jun 30, 2019 -1.12%
Mar 31, 2019 55.02%
Dec 31, 2018 -18.76%
Sep 30, 2018 3.74%
Jun 30, 2018 4.46%
Mar 31, 2018 -14.28%
Dec 31, 2017 1.35%
Sep 30, 2017 9.36%
Jun 30, 2017 20.16%
Mar 31, 2017 -0.57%
Dec 31, 2016 10.23%
Sep 30, 2016 0.19%
Jun 30, 2016 14.83%
Mar 31, 2016 1.85%
Dec 31, 2015 -1.24%
Sep 30, 2015 0.99%
Jun 30, 2015 -2.69%
Mar 31, 2015 2.48%
Dec 31, 2014 43.10%
Sep 30, 2014 5.54%
Jun 30, 2014 0.89%
Mar 31, 2014 0.99%
Dec 31, 2013 -1.33%
Sep 30, 2013 -0.59%
Jun 30, 2013 -2.67%
Mar 31, 2013 -1.30%
Dec 31, 2012 0.20%
Sep 30, 2012 0.19%
Jun 30, 2012 1.76%
Mar 31, 2012 -22.52%
Dec 31, 2011 -1.31%
Sep 30, 2011 5.22%
Jun 30, 2011 0.84%
Mar 31, 2011 -3.67%
Dec 31, 2010 -2.95%
Sep 30, 2010 3.60%
Jun 30, 2010 3.11%
Mar 31, 2010 0.29%